IPO Listed — 17 Dec 2025
Listing Price: ₹490 (+6.52% vs ₹460)
Nephrocare Health Services IPO Review
Nephrocare Health Services IPO has been reviewed by 10 analysts, and the overall consensus is Strong Apply — carrying a score of 100. Out of the 10 analysts who have covered this IPO, 10 recommend subscribing — reflecting a mixed view from the analyst community.
The issue is priced in the band of ₹438 – 460 per share , with a minimum application size of 32 shares (minimum investment of approximately ₹14,016 at the upper band) . Subscription ran from 10 Dec 2025 to 12 Dec 2025. Scroll down for the full analyst breakdown and analyst-wise verdicts.
General Review
Its ₹871.05 crore IPO (Dec 10–12, 2025) priced at ₹438–460 per share saw strong institutional subscription.
Proceeds will fund new clinics, debt repayment, and corporate purposes.
Shares listed with a positive debut on NSE/BSE.
Disclaimer: This review is an AI summary derived from the reviews of all analysts.
Table of Contents
Recommend Subscribe
Based on 10 analyst reviews
Higher consensus indicates broader analyst agreement.
Analyst Review
Latest IPO Reviews
Frequently Asked Questions
Should I apply for Nephrocare Health Services IPO?
Based on analyst coverage tracked on this page, the overall verdict for Nephrocare Health Services IPO is Strong Apply. Out of 10 analysts who have reviewed this IPO, 10 recommend subscribing. Always cross-check with the full analyst reviews below and consult a SEBI-registered advisor before making any investment decision.
What does the score of 100 mean for Nephrocare Health Services IPO?
The score of 100 is an aggregate of all analyst ratings tracked for Nephrocare Health Services IPO. A score in this range indicates strong analyst confidence — most analysts are recommending a subscribe. Scroll down to read individual analyst verdicts for more context.
What was the actual listing price of Nephrocare Health Services IPO?
Nephrocare Health Services IPO listed on December 17, 2025 at ₹490 , against the issue price of ₹460 — a gain of +6.52% (₹30 per share). View the full GMP history page for day-wise pre-listing trends.
What is the price band and lot size of Nephrocare Health Services IPO?
Nephrocare Health Services IPO was priced at ₹438 – 460 per share. The minimum lot size is 32 shares, making the minimum investment approximately ₹14,016 at the upper end of the price band. Subscription ran from 10 Dec 2025 to 12 Dec 2025.
Explore Nephrocare Health Services IPO Further
Track every stage of this IPO:
Discussion 0
No comments yet
Be the first to share your thoughts!